CANOPY GROWTH CORP COM NPV(OTCMKTS:TWMJF) Powers Higher

0

CANOPY GROWTH CORP COM NPV(OTCMKTS:TWMJF) continues to move higher in recent weeks towards its all time highs of $14.39. TWMJF is one exciting story developing in small caps and the largest Marijuana producer in Canada with global ambitions that has been seeing huge growth over the past year recently expanding its Tweed Farms to over 1,000,000 sq. ft. of greenhouse space under glass. The stock has seen a spectacular move up over the past few years from well under the $2 mark back in 2015 to all-time highs in November of of $14.39.

TWMJF is a powerhosue in the booming  Marijuana industry that has quickly turned into a multi-billion dollar massive growth market that is sweeping across North America. In the US legal Marijuana sales grew by an unprecedented 30% in 2016 to $6.7 billion as the legal market expands in the U.S. and Canada, according to a new report by Arcview Market Research. North American sales are projected to top $20.2 billion by 2021 assuming a compound annual growth rate of 25%. The report includes Canada for the first time as it moves towards implementing legal adult use marijuana.

CANOPY GROWTH CORP COM NPV(OTCMKTS:TWMJF) is Canada’s first publicly traded medical marijuana company and the first geographically diversified producer with multiple licenses under the Marijuana for Medical Purposes Regulations. Through its wholly owned subsidiaries, Tweed, Tweed Farms, and Bedrocan, it operates three state-of-the-art production facilities in Ontario and distributes marijuana across the country to Canadian patients managing a host of medical conditions. Canopy Growth is dedicated to educating healthcare practitioners, providing consistent access to high quality medication, conducting robust clinical research, and furthering the public’s understanding of how marijuana is used for medical purposes. After a recent expansion Tweed Farms will be home to over 1,000,000 sq. ft. of greenhouse space under glass, plus post-harvest facilities including a recently renovated 10,000 sq. ft. of updated space for new drying rooms and an upgraded laboratory.

TWMJF core brands include Tweed, the most recognized marijuana production brand in the world. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn’t just sell marijuana, it facilitates a conversation about a product we’ve all heard about but haven’t met intimately yet. It is approachable and friendly, yet reliable and trusted. As marijuana laws liberalize around the world, Tweed will expand its leading Canadian position around the globe.

TWMJF other core brand is Bedrocan, the epitome of medical-grade cannabis. Bedrocan BV pioneered medical cannabis in Holland through decades of selection and refinement, leading to standardized, whole bud cannabis strains that patients can rely on. Bedrocan Canada supplies the same standardized strains to the Canadian market through exclusive licensing rights to the American continents, an arrangement it will also enjoy for all future genetic advancements. Due to its consistency over time, Bedrocan’s strains have been used in clinical research in seven European countries. That commitment to research didn’t stay on the east side of the Atlantic – Bedrocan Canada recently launched one of the largest clinical cannabis studies in the world, the EQUAL Study, to evaluate quality of life before and after medical cannabis use.

To Find out the inside Scoop on TWMJF Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Earlier this year WEED said it has finalized the purchase of a parcel of land adjacent to its current facility in Niagara-on-the-Lake, ON including an operational 458,000 sq. ft. greenhouse. In addition to the newly acquired asset, construction has commenced on an additional 212,000 sq. ft. of state-of-the-art greenhouse to be located on the current Tweed Farms property, to be completed by April 2018.

All told, Tweed Farms will soon be home to over 1,000,000 sq. ft. of greenhouse space under glass, plus post-harvest facilities including a recently renovated 10,000 sq. ft. of updated space for new drying rooms and an upgraded laboratory. Canopy Growth purchased the property for $9 million with a combination of $6 million in cash and equity totalling up to $3 million in Canopy Growth common shares, of which $2 million is contingent on certain milestones, the latest issuance taking place no later than one year following the closing date of the transaction.  The total number of common shares issued on closing amounted to 111,366 and are subject to a four month lock up.

On September 28 TWMJF and Skinvisible Pharmaceuticals, Inc. (“Skinvisible”) (OTCQB: SKVI), a research and development company with a patented drug delivery system, today announced they have signed a definitive license agreement for Skinvisible’s patented topical formulations. Per the agreement, Canopy Growth is exclusively licensed to distribute Skinvisible’s topical products in Canada and shall have a first right of refusal for all other countries, excluding China and the United States.

The agreement covers two distinct product lines made with Skinvisible’s Invisicare® technology. Skinvisible will first develop unique topical hemp-based products that will be launched by Canopy Hemp Corporation in Canada. The agreement also includes potential cannabis-based topical products using the Invisicare® technology, when and if federal regulations permit CBD or THC infused topical products for sale in Canada.

“This agreement will have an immediate impact on our hemp product lines as this proven technology can be applied to a hemp oil product in today’s regulatory environment,” said Mark Zekulin, President, Canopy Growth. “Moving forward, cannabis product diversity will be increasingly important, and this agreement prepares us for future product opportunities on that side of our business, if and when the regulatory environment evolves.”

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $1 billion market valuation and running up the charts TWMJF has $115 million in cash and cash equivalents on the books, virtually no debt and significant fast growing revenues reporting $15,873,000 in sales for the 3 months ended June 30, 2017 up from $6,984 for the same period last year. Canopy Growth which is dually listed on both US and Canadian exchanges is one exciting story developing in small caps and the largest Marijuana producer in Canada with global ambitions.; the Company operates three state-of-the-art production facilities in Ontario and distributes marijuana across the country and is poised to emerge as the dominant player in the Canadian marijuana market once federal legalization takes effect on July 1st, 2018. TWMJF is becoming a leader in the red hot Marijuana industry that has quickly turned into a multi-billion dollar massive growth market and is a must own stock for Investors in pot stocks. We will be updating on TWMJF when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with TWMJF.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in TWMJF either long or short and we have not been compensated for this article.

Share.

Leave A Reply

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.